Patent Assignment
Reel/Frame 061774/0516
Assignment of Assignor's Interest
Recorded: 2022-11-15
Pages: 8
Assignor
CLARUS THERAPEUTICS, INC.
Executed: 2022-10-27
Assignee
TOLMAR, INC.
701 CENTRE AVE., FORT COLLINS, COLORADO, 80526
Covered Properties
(43)
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Application:
60/671,454 →
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Application:
60/721,971 →
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Compositions Comprising Same
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Application:
13/553,586 →
Publication:
US 2013/0022674
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Compositions Comprising Same
Application:
14/303,179 →
Publication:
US 2014/0296199
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Application:
14/820,749 →
Publication:
US 2016/0000806
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Application:
14/820,756 →
Publication:
US 2015/0343072
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Application:
14/820,761 →
Publication:
US 2015/0343073
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Application:
14/820,765 →
Publication:
US 2015/0343074
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Application:
15/723,955 →
Publication:
US 2018/0028542
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Application:
15/723,963 →
Publication:
US 2018/0021350
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Application:
15/723,970 →
Publication:
US 2018/0021351
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Application:
15/723,976 →
Publication:
US 2018/0078566
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Application:
16/183,155 →
Publication:
US 2019/0070196
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same
Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
Application:
14/290,540 →
Publication:
US 2014/0274986
Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same
Application:
17/814,296 →
Publication:
US 2023/0105163
Methods of Treating Testosterone Deficiency
Application:
61/794,055 →
Methods of Treating Testosterone Deficiency
Application:
14/216,240 →
Publication:
US 2014/0303129
Methods of Treating Testosterone Deficiency
Application:
15/458,240 →
Publication:
US 2017/0246184
Methods of Treating Testosterone Deficiency
Application:
16/360,583 →
Publication:
US 2020/0054648
Methods of Treating Testosterone Deficiency
Application:
17/001,127 →
Publication:
US 2021/0220374
Oral Pharmaceutical Products and Methods of Use Combining Testosterone Esters with Hypolipidemic Agents
Application:
61/920,982 →
Oral Pharmaceutical Products and Methods of Use Combining Testosterone Esters with Hypolipidemic Agents
Oral Pharmaceutical Products and Methods of Use Combining Testosterone Esters with Hypolipidemic Agents
Application:
16/274,968 →
Publication:
US 2020/0016172
Methods of Treating Testosterone Deficiency
Application:
62/508,195 →
Methods of Treating Testosterone Deficiency
Application:
15/984,028 →
Publication:
US 2018/0333423
Methods of Treating Testosterone Deficiency
Application:
16/295,427 →
Publication:
US 2020/0038411
Methods of Treating Testosterone Deficiency
Application:
62/782,865 →
Methods of Treating Testosterone Deficiency
Application:
16/720,194 →
Publication:
US 2020/0197413
Methods of Treating Testosterone Deficiency
Application:
17/235,439 →
Publication:
US 2022/0088034
Methods of Treating Testosterone Deficiency
Oral Pharmaceutical Products and Methods of Use Combining Testosterone Esters with Anti-Hypertensive Agents
Application:
62/833,189 →
Methods of Treating Testosterone Deficiency
Application:
16/720,183 →
Publication:
US 2020/0197412
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 15, 2005
From: DUDLEY, ROBERT E., PH.D.
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 016487/0066 →
Assignment of Assignor's Interest
Apr 15, 2005
From: CONSTANTINIDES, PANAYIOTIS P.
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 016478/0929 →
Assignment of Assignor's Interest
Sep 30, 2005
From: CONSTANTINIDES, PANAYIOTIS P.
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 017052/0414 →
Assignment of Assignor's Interest
Sep 30, 2005
From: DUDLEY, PH.D., ROBERT E.
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 017052/0401 →
Assignment of Assignor's Interest
Nov 8, 2007
From: DUDLEY, ROBERT E.; CONSTANTINIDES, PANAYIOTIS P.
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 020084/0745 →
Assignment of Assignor's Interest
Jun 22, 2010
From: DUDLEY, ROBERT E.; CONSTANTINIDES, PANAYIOTIS P.
To: CLARUS THERAPEUTIS, INC.
Reel/Frame 024578/0417 →
Assignment of Assignor's Interest
Jan 17, 2013
From: DUDLEY, ROBERT E; CONSTANTINIDES, PANAYIOTIS P
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 029650/0194 →
Assignment of Assignor's Interest
Jan 17, 2013
From: DUDLEY, ROBERT E; CONSTANTINIDES, PANAYIOTIS P
To: CLARUS THERAPEUTICS, INC
Reel/Frame 029649/0926 →
Assignment of Assignor's Interest
Feb 24, 2014
From: DUDLEY, ROBERT E; CONSTANTINIDES, PANAYIOTIS E
To: CLARUS THERAPUETICS, INC.
Reel/Frame 032285/0101 →
Corrective Assignment to Correct the Spelling of Assignor's Name and Assigness's Name Previously Recorded on Reel 032285 Frame 0101. Assignor(S) Hereby Confirms the Assignment of Assignor's Interest.
May 21, 2014
From: DUDLEY, ROBERT E.; CONSTANTINIDES, PANAYIOTIS P.
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 032971/0273 →
Corrective Assignment to Correct the the Spelling of Assignee's Name Previously Recorded on Reel 024578 Frame 0417. Assignor(S) Hereby Confirms the Assignment of Assignor's Interest.
May 21, 2014
From: DUDLEY, ROBERT E.; CONSTANTINIDES, PANAYIOTIS P.
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 032971/0475 →
Assignment of Assignor's Interest
Jul 29, 2014
From: DUDLEY, ROBERT E; CONSTANTINIDES, PANAYIOTIS P
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 033412/0188 →
Assignment of Assignor's Interest
Jul 29, 2014
From: DUDLEY, ROBERT E; CONSTANTINIDES, PANAYIOTIS P
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 033412/0354 →
Assignment of Assignor's Interest
Aug 25, 2015
From: DUDLEY, ROBERT E.; CONSTANTINIDES, PANAYIOTIS P.
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 036416/0438 →
Assignment of Assignor's Interest
Dec 13, 2016
From: DUDLEY, ROBERT E; CONSTANTINIDES, PANAYIOTIS P
To: CLARUS THERAPEUTICS, INC
Reel/Frame 040721/0172 →
Assignment of Assignor's Interest
Jan 12, 2017
From: DUDLEY, ROBERT E; CONSTANTINIDES, PANAYIOTIS P
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 040958/0709 →
Assignment of Assignor's Interest
Oct 5, 2017
From: DUDLEY, ROBERT E.; CONSTANTINIDES, PANAYIOTIS P.
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 043795/0908 →
Assignment of Assignor's Interest
Nov 15, 2017
From: DUDLEY, ROBERT E.; CONSTANTINIDES, PANAYIOTIS P.
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 044139/0534 →
Security Interest
Mar 12, 2020
From: CLARUS THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 052099/0349 →
Assignment of Assignor's Interest
Dec 14, 2020
From: DUDLEY, ROBERT E.; CONSTANTINIDES, PANAYIOTIS P.
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 054641/0925 →
Release of Security Interest
Dec 6, 2022
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS SUCCESSOR TO U.S. BANK NATIONAL ASSOCIATION
To: CLARUS THERAPEUTICS, INC.
Reel/Frame 062000/0052 →